jRCT2080222876未知2 期
Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge Chamber
试验速览
- 阶段
- 2 期
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Single-center, randomized, double-blind, placebo-controlled, parallel-group
入排标准
- 年龄范围
- 12age old over 至 49age old under（—）
- 性别
- All
入选标准
- •Allergy test-positive patients who experienced symptoms of Japanese cedar pollinosis in the last two years or more.
排除标准
- •Patients who potentially have allergic rhinitis, conjunctivitis or asthma caused by any allergens except for Japanese cedar pollen antigens.
结局指标
主要结局
-
Efficacy, safety
次要结局
未报告次要终点
研究者
相似试验
未知
2 期
Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge ChamberJapanese cedar pollinosisJPRN-jRCT2080222876Shionogi & Co., Ltd.
已完成
2 期
A Phase 2, Double-blind Study of S-005151 in Patients with Acute Ischemic StrokejRCT2080224879SHIONOGI & CO., LTD.150
已完成
2 期
A Phase 2, Double-blind Study of S-005151 in Patients with Acute Ischemic StrokeAcute Ischemic StrokeJPRN-jRCT2080224879SHIONOGI & CO., LTD.150
未知
2 期
A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic RhinitisAllergic rhinitisJPRN-jRCT2080221872SHIONOGI & CO., LTD.
已完成
2 期
A phase 2, open-label study of S-646240 in patients with age-related macular degeneration accompanied by choroidal neovascularizatioAge-related macular degenerationJPRN-UMIN000008040Shionogi & Co., Ltd.40